Palatin Technologies(PTN) - 2024 Q2 - Earnings Call Transcript

Joe Pantginis Okay. No idea what happened there because I don't even have a mute on this phone -- I was not on mute. Anyway, so I was hoping maybe starting at the back end of your comments about providing some level of the mechanistic rationale of combining bremelanotide with GLP-1 agonist or one of those therapies for weight loss right now about -- whether it could be the maintenance setting or why those two drugs can really work together for the broader audience? Carl Spana Sure. I'll try to do it in a si ...